lonapalene has been researched along with masoprocol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kreft, AF; Musser, JH | 1 |
Batt, DG; Galbraith, W; Harris, RR; Maynard, GD; Petraitis, JJ; Shaw, JE | 1 |
Gawlik, I; Leukel, P; Müller, K; Ziereis, K | 1 |
Gürster, D; Müller, K; Piwek, S; Wiegrebe, W | 1 |
1 review(s) available for lonapalene and masoprocol
Article | Year |
---|---|
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Asthma; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases; Neutrophils; Quinolines | 1992 |
3 other study(ies) available for lonapalene and masoprocol
Article | Year |
---|---|
2-substituted-1-naphthols as potent 5-lipoxygenase inhibitors with topical antiinflammatory activity.
Topics: Animals; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Chemical Phenomena; Chemistry; Dermatitis; Ear Diseases; Edema; Leukemia, Basophilic, Acute; Lipoxygenase Inhibitors; Molecular Structure; Naphthols; Rats; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition.
Topics: Administration, Topical; Animals; Anthracenes; Anti-Inflammatory Agents; Antioxidants; Cattle; Cell Division; Cells, Cultured; Humans; Hydroxyeicosatetraenoic Acids; Keratinocytes; Leukotriene B4; Lipid Peroxidation; Liposomes; Lipoxygenase Inhibitors; Malondialdehyde; Molecular Structure; Neutrophils; Oxidation-Reduction; Psoriasis; Structure-Activity Relationship | 1994 |
Antipsoriatic anthrones with modulated redox properties. 1. Novel 10-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of 5-lipoxygenase.
Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Cattle; Lipoxygenase Inhibitors; Neutrophils; Oxidation-Reduction; Structure-Activity Relationship | 1993 |